title: Drug may slow progression and increase prostate cancer survival. A Duke study is one of three recently published investigations that reflect progress against the disease that affects millions of men.
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use*; D018450:Disease Progression; D006801:Humans; D008297:Male; D011471:Prostatic Neoplasms / Q000145:classification / Q000188:drug therapy*; D011804:Quinolines / Q000627:therapeutic use*; D015363:Quinolones; D016019:Survival Analysis
chemical_list: D000970:Antineoplastic Agents; D011804:Quinolines; D015363:Quinolones; C516109:tasquinimod